This role for CXCR3 is distinct from its expression by tumor cells to achieve metastatic engraftment13, 16, 31, and prior studies using systemic therapies to block CXCR3 signaling have not delineated the relative contributions. The gene discussed is CXCR3; the disease is neoplasm.